Crosstalk between LXR and Toll-like Receptor Signaling Mediates Bacterial and Viral Antagonism of Cholesterol Metabolism

Autor: Peter Tontonoz, Antonio Castrillo, Genhong Cheng, Sagar A. Vaidya, M E Haberland, Sean B. Joseph, Alan M. Fogelman
Rok vydání: 2003
Předmět:
Arteriosclerosis
Receptors
Cytoplasmic and Nuclear

Receptors
Cell Surface

Ligands
Cell Line
Mice
Genes
Regulator

polycyclic compounds
Animals
Receptors
Immunologic

Promoter Regions
Genetic

Liver X receptor
Molecular Biology
Adaptor Proteins
Signal Transducing

Liver X Receptors
Mice
Knockout

Toll-like receptor
Membrane Glycoproteins
Innate immune system
biology
Effector
Macrophages
Toll-Like Receptors
NF-kappa B
Bacterial Infections
Cell Biology
Orphan Nuclear Receptors
Antigens
Differentiation

Toll-Like Receptor 3
Cell biology
DNA-Binding Proteins
Mice
Inbred C57BL

Crosstalk (biology)
Cholesterol
Gene Expression Regulation
Biochemistry
Virus Diseases
ABCA1
Myeloid Differentiation Factor 88
TLR3
biology.protein
ATP-Binding Cassette Transporters
Interferon Regulatory Factor-3
lipids (amino acids
peptides
and proteins)

Signal transduction
ATP Binding Cassette Transporter 1
Signal Transduction
Transcription Factors
Zdroj: Molecular Cell. 12:805-816
ISSN: 1097-2765
DOI: 10.1016/s1097-2765(03)00384-8
Popis: The liver X receptors (LXR) alpha and beta are regulators of cholesterol metabolism and determinants of atherosclerosis susceptibility. Viral and bacterial pathogens have long been suspected to be modulators of atherogenesis; however, mechanisms linking innate immunity to cholesterol metabolism are poorly defined. We demonstrate here that pathogens interfere with macrophage cholesterol metabolism through inhibition of the LXR signaling pathway. Activation of Toll-like receptors (TLR) 3 and 4 by microbial ligands blocks the induction of LXR target genes including ABCA1 in cultured macrophages as well as in aortic tissue in vivo. As a consequence of these transcriptional effects, TLR3/4 ligands strongly inhibit cholesterol efflux from macrophages. Crosstalk between LXR and TLR signaling is mediated by IRF3, a specific effector of TLR3/4 that inhibits the transcriptional activity of LXR on its target promoters. These findings highlight a common mechanism whereby bacterial and viral pathogens may modulate macrophage cholesterol metabolism and cardiovascular disease.
Databáze: OpenAIRE